Biotechnology Innovation Organization’s Post

FDA approves Donanemab for early symptomatic AD. APOE4 testing recommended, not compulsory and patients can be on anticoagulants, if I read correctly. Lots of interesting things here

Groundbreaking Alzheimer's Therapy Targets Amyloid Plaques INDIANAPOLIS, July 2, 2024 /PRNewswire/ -- The FDA has approved Kisunla™ (donanemab-azbt, 350 mg/20 mL once-monthly injection for IV infusion), Eli Lilly's revolutionary treatment for early symptomatic Alzheimer's disease. Kisunla is the first amyloid plaque-targeting therapy with evidence supporting therapy cessation once plaques are removed, potentially lowering treatment costs and reducing infusions. This breakthrough offers hope to those with mild cognitive impairment and early-stage dementia. As with all therapies, consult your doctor before starting treatment. #AlzheimersBreakthrough #Kisunl #AmyloidPlaques #DementiaTreatment #CognitiveHealth #Neurology #AlzheimersAwareness #MedicalInnovation

🚀 Exciting News in Alzheimer's Treatment! 🚀 禮來 Eli Lilly's new drug, Kisunla™, has demonstrated incredible results, slowing cognitive decline by 35% and reducing disease progression risk by 39%. This first-of-its-kind therapy, requiring once-monthly infusions, also achieved an 84% reduction in amyloid plaques. Effective tracking of this medication is crucial to ensure patient safety and inform clinical strategies. To enhance patient monitoring, Instant NanoBiosensors offers a groundbreaking blood detection system that is: 🌍High Accessibility: Designed for portability and ease of use 🌍Low Cost: Detection costs can be reduced by at least 50% 🌍Ultra-Sensitivity: Detection limit in the range of pg/mL to fg/mL We are eager to combine Kisunla’s innovative treatment with Instant NanoBiosensors' advanced monitoring to revolutionize Alzheimer’s care, improving outcomes and providing new hope for patients. 💪 #HealthcareInnovation #AlzheimersTreatment #Biotech #PatientCare #EliLilly #InstantNanoBiosensors

Clinical research and development that is life changing. This approval is amazing and will be life changing for so many. This hits close to home and is personal for me and my family. Wonderful news for society, Lilly - the hard work has now come to fruition. #lifechanging #dementia #alzheimers #personal #clinicalresearch #clinicaldevelopment #neuroscience #hitshome #patientsfirst #caregivers #providers

Did you know that 1 in 30 people aged 12 or older misused CNS stimulants (cocaine, prescription stimulants, or methamphetamine)? The infographic summarizes results from the 2022 National Survey on Drug Use and Health (NSDUH). For more data and details, go to: bit.ly/3SStGRD #SubstanceMisuse #CentralNervousSystem #substanceusedisorder #prevention #preventionworks

Be safe: register to receive urgent alerts about drug recalls and withdrawals! 📣 If you take clotting factor or immune globulin medications, consider registering with the Patient Notification System (from PPTA). When you register, you'll be able to receive instant alerts, via text or email, if there is a drug recall or withdrawal that affects you and your medication. Learn more at https://lnkd.in/eghQiBHr. Registration is free and confidential. #HPC #PPTA #drugrecalls

Did you know that adverse drug events (ADEs) are the 4th leading cause of death in the United States? These medication-related problems can include falls, emergency room visits, hospitalizations, and potentially death. With the right information based on your DNA, many adverse drug events can be prevented. As part of our personalized medication safety program, our clinical-grade Pharmacogenomic (PGx) Testing indicates how (and if) a policyholder will respond to a particular medication and if they are more likely to have an ADE or side effect. Our program provides insights to help a policyholder’s healthcare provider select the right medication and dosage based on the individual's DNA. No more one medication fits all. #MedicationSafety #Pharmacogenomics #PersonalizedMedicine #DidYouKnow #PrecisionHealth

Adverse Drug Events (ADEs) contribute to 1 in 9 emergency department visits. Even more concerning, 1 in 3 of these are due to repeated prescriptions of the same drug. ActionADE is an application that allows providers to document and communicate standardized ADE information to prevent re-exposures to harmful medications. “When you go to a doctor, they can generally look up all your medications. What they don’t know is if you’ve had problems with certain drugs,” shares Glen Medcalf, who experienced several adverse reactions to his diabetes medication. “ActionADE could ensure that specialists, general practitioners or hospital staff have the information needed to act quickly on your past history.” Discover Glen's journey: https://ow.ly/xmkq50Ta3a4 #HealthResearch #EmergencyCare #AdverseDrugEvents

The US FDA Approved Cormedix Inc.’s DefenCath for the Reduction of Catheter-Related Bloodstream Infections (CRBSI) In Adult Hemodialysis Patients #cormedix #defencath #hemodialysis #kidneyfailure #regulatory #usfda #approval #catheterlocksolution #catheterrelatedbloodstreaminfections #centralvenouscatheter #hazardratio #taurolidine #safety #efficacy #incidence #statisticallysignificant #antimicrobialagent

Prescription drugs are the third most misused substance after marijuana and alcohol in teens. Many teens obtain prescription medication from family or friends because they can easily find the medications in their own home. In 2021, 44.9% of persons aged 12 or older who misused a prescription pain reliever obtained the medication from a friend or relative. Prevent medication misuse or overdose with proper storage and disposal. To learn more about teens and medication misuse visit: https://lnkd.in/g2_9ya46 (Link). To learn how to safely dispose of unused medications in your county by accessing Iowa Healthcare Collaborative safe medication disposal page: https://lnkd.in/gtuvngvN (Link). #DEA #Opioids #OpioidCrisis #SafeDisposal #SecureYourMeds